Julia Wanschitz

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease

Johannes A. Hainfellner, Julia Wanschitz, K. A. Jellinger et al. · Acta Neuropathologica · 1998 · 143 citations

Alzheimer's Disease, Creutzfeldt-jakob Disease, Dementia +6

Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barre syndrome

Julia Wanschitz · Brain · 2003 · 114 citations · Full text

T-regulatory Cell, Immune Regulation, Immunology +22

Functional defects due to spacer-region mutations of human mitochondrial DNA polymerase in a family with an ataxia-myopathy syndrome

Petri Luoma, Ningguang Luo, Wolfgang N. Löscher et al. · Human Molecular Genetics · 2005 · 110 citations

Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study

Verena Rass, Ronny Beer, Alois Josef Schiefecker et al. · European Journal of Neurology · 2022 · 110 citations · Full text